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Kandić M, Moliadze V, Andoh J, Flor H
and Nees F (2021) Brain Circuits
Involved in the Development of
Chronic Musculoskeletal Pain:
Evidence From Non-invasive Brain
Stimulation. Front. Neurol. 12:732034.
doi: 10.3389/fneur.2021.732034
Brain Circuits Involved in the
Development of Chronic
Musculoskeletal Pain: Evidence From
Non-invasive Brain Stimulation
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It has been well-documented that the brain changes in states of chronic pain. Less
is known about changes in the brain that predict the transition from acute to chronic
pain. Evidence from neuroimaging studies suggests a shift from brain regions involved
in nociceptive processing to corticostriatal brain regions that are instrumental in the
processing of reward and emotional learning in the transition to the chronic state.
In addition, dysfunction in descending pain modulatory circuits encompassing the
periaqueductal gray and the rostral anterior cingulate cortex may also be a key risk
factor for pain chronicity. Although longitudinal imaging studies have revealed potential
predictors of pain chronicity, their causal role has not yet been determined. Here we
review evidence from studies that involve non-invasive brain stimulation to elucidate to
what extent they may help to elucidate the brain circuits involved in pain chronicity.
Especially, we focus on studies using non-invasive brain stimulation techniques [e.g.,
transcranial magnetic stimulation (TMS), particularly its repetitive form (rTMS), transcranial
alternating current stimulation (tACS), and transcranial direct current stimulation (tDCS)]
in the context of musculoskeletal pain chronicity. We focus on the role of the motor
cortex because of its known contribution to sensory components of pain via thalamic
inhibition, and the role of the dorsolateral prefrontal cortex because of its role on
cognitive and affective processing of pain. We will also discuss findings from studies
using experimentally induced prolonged pain and studies implicating the DLPFC, which
may shed light on the earliest transition phase to chronicity. We propose that combined
brain stimulation and imaging studies might further advance mechanistic models of the
chronicity process and involved brain circuits. Implications and challenges for translating
the research on mechanistic models of the development of chronic pain to clinical
practice will also be addressed.
Keywords: non-invasive brain stimulation, transcranial magnetic stimulation, transcranial alternating current
stimulation, transcranial direct current stimulation, development of chronic musculoskeletal pain, brain
mechanisms
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INTRODUCTION
Chronic musculoskeletal pain is defined as a persisting or
reoccurring pain that originates in musculoskeletal structure (1).
In the new ICD-11 classification it is listed under the chronic
primary pain category where it is recognized as a “disease in its
own right” that cannot be explained by another disease (2).
Living with chronic musculoskeletal pain is a great burden
to an individual experiencing pain, along with large-scale
implications for society including enormous medical annual
costs worldwide, the occurrence of sick leave, and work disability
(3). Despite these high individual and societal costs, efforts
to effectively treat chronic pain have been met with moderate
success and in many patients, chronic pain remains untreated or
poorly treated (4). The prevention of the transition from acute to
chronic pain is therefore an important goal. The mechanisms of
this transition remain, however, poorly understood (4).
Research has revealed that the brain in chronic and acute pain
stage differs (5). However, the relationship between changes in
a certain brain circuit and pain is never one-dimensional, since
these alterations in the brain can relate to other factors such
as medication intake and affective comorbidity (6–8). Since it
has been shown that circuits that subserve emotional, learning,
reward, andmemory processes are key factors in the development
of chronicity, these mechanisms themselves could be driving
forces or catalysts of the transition (9–11). Moreover, genetic,
and epigenetic factors (12), physiological and psychosocial
expressions of stress (13, 14), have also been implicated in the
development of chronic musculoskeletal pain. This stresses the
importance of considering these factors when modeling and
investigating brain-pain relationship. A mechanistic model of
pain therefore acknowledges several key elements and their
interaction in chronic pain pathogenesis and maintenance (15).
Multiple emotional and cognitive factors impact on the
experience of pain, thus brain circuits involved in the processing
of emotion might play an important role in the development
of chronic pain (16, 17). Evidence from longitudinal imaging
studies suggests a shift from brain regions involved in nociceptive
processes toward brain areas supporting emotion, motivation,
and memory processes when acute musculoskeletal pain persists
(5, 18). Such findings are an important step toward unraveling
neural changes associated with chronic pain.
Although neuroimaging studies allowed to further advance
our knowledge about plastic changes related to pain chronicity,
they cannot provide causal relationships between them. In this
context, non-invasive brain stimulation (NIBS) methods have
been used to modulate cortical excitability in specific brain
areas, in order to show a direct relationship between brain and
behavior. NIBS allows a step further into the understanding on
the mechanisms of pain, acute and chronic, and can be applied
on both healthy participants and chronic pain patients (19).
In this review, we will present an overview of the available
NIBS studies with respect to pain development and discuss these
studies in the context of a mechanistic understanding of pain
chronicity. We further review to what extent NIBS studies offer
additional targets on brain circuits (see Figure 1) involved in
transition from acute to chronic pain. Lastly, we suggest future
directions for NIBS research and discuss implications for the
clinical practice.
NEURAL CIRCUITS INVOLVED IN
CHRONIC MUSCULOSKELETAL PAIN:
NEUROIMAGING EVIDENCE
Neuroimaging studies in chronic pain patients have revealed
altered structure and function of the brain in chronic
pain. Studies in fibromyalgia, chronic tension-type headache,
and chronic back pain patients have reported structural
and functional changes in regions not typically involved in
nociceptive processing, such as limbic and prefrontal cortices (16,
20, 21). Furthermore, the default mode network (DMN), which is
active in the absence of any task to maintain resting brain activity
and is deactivated during task-based fmri (functional magnetic
resonance imaging), showed persistent increased activity rather
than deactivation in chronic pain patients (22) and abnormal
functional connectivity with other brain regions at rest (23, 24)
that was associated with the duration of chronic pain (24, 25).
In addition, the brain of chronic pain patients might
differentially process acute and chronic pain, with the prefrontal
cortex being a key region for this dissociation (16). Moreover,
the prefrontal cortex is also believed to constitute one of the
key regions in descending inhibitory pathways (26), and this
pathway has also been found to be impaired in many chronic
pain conditions, including chronic musculoskeletal pain (27, 28).
Neuroimaging evidence documented distinct neural patterns for
tonic and chronic pain in comparison to experimental phasic
pain, with somatomotor, frontoparietal, and dorsal attention
networks emerging as key circuits (29).
From the few available longitudinal data, it seems that similar
networks are involved in the acute to chronic transition process,
and that particularly corticostriatal circuits play an important
role in pain chronicity. In a sample of subacute back pain
patients followed over 1 year, increased functional connectivity
between the medial prefrontal cortex (mPFC) and the nucleus
accumbens (NAc) (18), and decreased hippocampal-medial
prefrontal cortex functional connectivity during spontaneous
pain were found predictive for the transition to pain chronicity
(30). In addition, volumes of amygdala, hippocampus (31), and
NAc (32) could predict chronic pain development. In further
support of these results, denser white matter corticolimbic
connections, specifically between mPFC and NAc, predicted the
shift to the chronic state after a 1 year period (33).
NON-INVASIVE BRAIN STIMULATION:
BASIC PRINICIPLES AND FINDINGS IN
CHRONIC MUSCULOSKELETAL PAIN
Twomethods of non-invasive transcranial brain stimulation have
dominated recent decades: transcranial magnetic stimulation
(TMS), which activates axons through short-pulsed stimulation
and leads thereby to new action potentials; and transcranial
electric stimulation (tES), most used transcranial direct current
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FIGURE 1 | Brain targets involved in the mechanism of pain chronicity. Cortical targets of NIBS studies were primary motor cortex (M1), primary somatosensory
cortex (S1), dorsolateral prefrontal cortex (DLPFC), and occipital field (OCF). Imaging studies have identified thalamus, hippocampus (Hipp), amygdala (AMY), and
nucleus accumbens (NAc) as key subcortical regions implicated in pain chronicity. Anterior cingulate cortex (ACC) has been identified as an important relay in the
medial pain pathway integrating sensory, attentional, and motivational components of pain that can also been targeted via cortical stimulation due to its
interconnections with these targets. In tonic, acute pain stage, motor cortex, as well as somatosensory regions may undergo rapid changes as response to peripheral
insult, and the magnitude of this response might be shaped by pre-existing individual differences within these regions. As demonstrated in NIBS studies, DLPFC
regulates top-down inhibition of pain independently of motor cortex activation, possibly modulating sensory component in an early stage of pain development. As pain
develops to the chronic stage, cognitive aspects of pain become more important mechanism and prefrontal regions may regulate the affective component of pain via
their influence on cingulate and limbic circuits.
stimulation (tDCS), which can be used to manipulate the
membrane potential of neurons andmodulate spontaneous firing
rates, but which by itself is not sufficient to discharge resting
neurons or axons (34).
Transcranial Magnetic Stimulation
TMS operates on the electromagnetic induction principle
(35). The device unit typically encompasses a capacitor that
accumulates and discharges a rapidly changing current of high
voltage through the transducing coil placed to the subject’s head.
This sequentially creates a powerful (2–3 T) and brief (100–200
µs) magnetic field in the wires of the coil, inducing in turn an
electrical field perpendicular to the coil surface in the neural
tissue beneath the coil (36). The current induced at the neuronal
layer is attenuated through the cranium and extracerebral tissues,
yet it can exert enough strength to act in a suprathreshold
manner and elicit an action potential (37). TMS primarily affects
neurons in superficial areas directly below the coil, where the
intensity of the current decays with the distance away from the
coil (38). Different coils produce slightly different electrical field
strengths and spreads, but all follow a depth-focality trade-off
(39). Apart from local effects, stimulation can induce distant
effects via propagation to interconnected regions belonging to
the same neural network (40). Spread of the current is dependent
on individual and tissue properties, which, however, cannot be
controlled, and stimulation parameters that can be selected such
as geometry of the coil, pulse waveform, intensity, frequency, and
number of delivered pulses (41, 42).
A range of combinations of possible parameters constitutes
the stimulation patterns that serve different purposes. For
example, single pulses are applied in studies that investigate
functioning of brain regions, while paired pulse regimes can be
used to explore inhibitory or excitatory intracortical networks or
connectivity of two cortical regions via conduction time that two
successive pulses induce between them (43). When delivered in
repetitive stimulation trains, the TMS regime is termed repetitive
transcranial magnetic stimulation with low repetition rates under
or at about 1Hz decreasing excitation, whereas high frequencies
of ≥5Hz are generally believed to increase excitability of
stimulated region (36). Due to the short interstimulus period,
effects of rTMS sum up and can modulate neural activity
beyond the stimulation period, thereby promoting neuronal
plasticity (44). It is assumed that rTMS after-effects are based
on long-term potentiation (LTP) and long-term depression-like
(LTD)-like mechanisms of synaptic plasticity (36, 37). Recently,
neurostimulation research has become interested in theta-burst
stimulation (TBS), a modification of high-frequency rTMS.
There is evidence that TBS produces even more robust changes
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in cortical excitability than those observed in the conventional
rTMS protocols. TBS typically consists of bursts of three pulses at
30Hz or 50Hz, repeated five times per second with 600 pulses in
total (i.e., at theta frequency). There are two different paradigms:
intermittent TBS (iTBS) and continuous TBS (cTBS). While iTBS
facilitates CE, cTBS attenuates it (45–49). The advantage of TBS
as compared to low and high frequency rTMS is that by using
a similar number of pulses but considerably shorter duration
and lower intensity of stimulation, experimental time is reduced
without jeopardizing effect strength.
Using TMS, the brain can be briefly activated or briefly
inhibited. Applications were first in the motor system and have
now been used to map sensory processes and cognitive function.
When TMS is delivered onto the primary motor cortex, it
has the capacity to initiate descending volleys from pyramidal
axons to spinal motor neurons, as demonstrated by epidural
recordings in anesthetized humans (50). When the target of
stimulation is a region subserving higher cortical function,
TMS can interfere with neuronal firing and intercommunication
within that region, which has been termed “virtual lesion” and
reflects a momentary disruption of ongoing neuronal activity
(51). Corresponding effects in the cognitive and/or behavioral
domain can be measured through specific tasks, and enable to
establish brain-behavior relationships. Such change in behavior
can be observed online, i.e., being the product of concurrent
stimulation, or offline, i.e., immediately after or up to an
hour after the stimulation period, called after-effects. These
effects emerge as a result of repeated depolarization events that
temporally change neuronal firing (40).
Transcranial Direct and Alternating Current
Stimulation
Transcranial current stimulation employs electric current
through two or more surface electrodes attached directly to
scalp and connected to the battery-driven stimulator (52). Unlike
strong magnetically induced electric field in TMS, electrical
current produced by TES (Transcranial electrical stimulation)
is of weaker potential (53). This leaves the neural tissue excited
below the necessary threshold to produce an action potential, but
sufficient to modulate the firing of neurons in case of upcoming
neural input (54). In general, direct current has been shown to
influence a range of different neurotransmitters [for review, see
(55)], while the long-lasting effects thought to induce plasticity
have been attributed to the modulation of the N-Methyl-D-
aspartate (NMDA) receptors and GABAmodulation has a gating
function on respective plasticity (56, 57).
The most common bipolar montage comprises of anode
and cathode electrodes, producing polarity-specific modulation
effects. Following the simplified assumption, in tDCS, a constant
current flows between the electrodes, with anodal stimulation
increasing cortical excitability and cathodal stimulation
decreasing it (58). Similarly to TMS, the modulatory effects
induced by tDCS depend on the choice of electric current
intensity, waveform, and position and size of electrodes (59).
Computational modeling studies suggested that current flow is
mostly focused under the stimulated electrode (53), although
human imaging studies showed that tDCS could even modulate
spinal network excitability (60), which is in line with animal
studies showing spread of tDCS-related effects to subcortical
networks (61). Novel approaches emerged to improve spatial
targeting, such as high definition transcranial current stimulation
(HD-tCS) (62) or network-targeted multichannel stimulation
(net-tCS) (63, 64) that make use of multiple electrodes
improving focality.
Transcranial alternating current stimulation (tACS) occupies
intermediate positions, in the physical sense, between pulsed
rTMS and continuous tDCS. In tACS, the electrical current
alternates between electrodes, usually in a sinusoidal form (65).
The exact mechanisms by which tACS modulates brain activity
are still not fully understood, five common explanations for
direct, modulatory “online” effects include stochastic resonance
and rhythm resonance, temporal biasing of spikes, network
entrainment and imposed patterns (66). These mechanisms
are assumed to affect activity in larger networks in the brain.
Contrary to these suggested direct online mechanisms of
electrical stimulation, the after-effects of tACS likely depend on
the induction of neural plasticity (67). When brain activity is
aimed to bemodulated in a frequency-specificmanner, tACS is an
unprecedented method of choice, since it can target and interfere
with the specific intrinsic oscillations of the brain region (68).
There is a substantial variability of responses to NIBS
techniques across subjects on an individual level (69). Beside the
methodological factors of stimulation, which generally affect both
inter- and intra-subject variability, there is a number of other
determinants which have to be taken into account including
anatomical features of the head and brain (70), initial level
of brain function (71, 72), genetics (73), development, and
aging (74).
NIBS Studies on the Transition to Chronic
Musculoskeletal Pain
The two most explored NIBS targets in pain are the primary
motor cortex (M1) (19), which has been shown to undergo
reorganization in chronic pain conditions (75), and the
dorsolateral prefrontal cortex (DLPFC), due to its role in
the affective and motivational components of pain (76). We
discuss the contribution of NIBS studies targeting these two
regions in the mechanistic understanding of chronic pain
development. We then discuss additional NIBS targets that could
potentially be beneficial to provide a mechanistic explanation of
pain chronicity.
To uncover the mechanisms behind pain chronicity, the
NIBS studies that are helpful are the ones that (1) focus on an
experimental induction of prolonged pain in healthy individuals
and follow the course of pain progression and pain resolution,
thus providing a time course of pain development in relation
to extended painful stimulation, or (2) focus on stimulation
effects on clinical and induced pain in chronic pain patients
to disentangle brain alterations from non-clinical compared
to functionally and structurally altered clinical brain states, in
relation to findings from (1).
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Studies of Long-Term Pain Induced in Healthy
Subjects
Through the experimental application and manipulation of pain
in healthy individuals, we can monitor the time course when
pain develops and gradually resolves and relate these changes
with other clinical or neural measures. Prolonged pain in healthy
humans can mimic symptoms seen in chronic conditions such as
increased pain sensitivity (hyperalgesia), increased sensitivity to
sensory stimuli (allodynia), or muscle soreness (77, 78).
Among the available NIBS studies of long-term pain induced
in healthy subjects, NIBS has been used in the context of
central sensitization, which has been proposed to underlie pain
chronicity (79), and can manifest as secondary hyperalgesia
or increased pain sensitivity at non-painful remote sites (80),
and allodynia, painful sensation to usually non-noxious stimuli
(81), shown in chronic back pain (82) and fibromyalgia (83).
Available TMS studies applied both, stimulation protocols
(rTMS) to modulate neural activity, and single pulse TMS as a
measurement protocol to investigate cortical excitability changes
and organization within the circuits of the motor cortex network.
Motor Cortex
Motor cortex was often targeted with NIBS due to analgesic
effects that stimulation of this region has exhibited, most
successfully when the target within M1 was the somatotopic
representation of the painful body area (84).
Meeker et al. (85) delivered 1mA over the left M1 following
the application of capsaicin on the right leg of 27 healthy
subjects. They used capsaicin—heat pain model (C-HP model)
where the thermode was attached to the participant’s leg
after the incubation of capsaicin applied into the bandage on
the right leg. Warmth, heat, mechanical pain thresholds and
suprathreshold mechanical pain ratings were obtained before
the heat exposure, and the heat pain scores were assessed every
minute throughout the heat exposure. Anodal tDCS started
12min after the application of capsaicin and was delivered
for 20min. Additionally, extent and intensity of secondary
mechanical hyperalgesia, and residual heat pain intensity were
assessed at four time points, up to 65min after removal
of capsaicin and tDCS stimulation. In addition, 15 subjects
from this study who have developed secondary mechanical
hyperalgesia underwent three fMRI sessions before and after
the application of the C-HP model receiving either anodal,
cathodal, or sham tDCS in each session. Painful mechanical
stimuli using weighted probes were assessed during and after
the scanning sessions. Anodal tDCS renormalized the BOLD
activation in several brain regions including mPFC, pregenual
anterior cingulate cortex (pgACC), the periaqueductal gray
(PAG), and brainstem, whose activity was prominent in response
to mechanical pain, supporting the involvement of descending
inhibitory circuits to supress prolonged influx of nociceptive
stimuli (85). However, no effect of anodal stimulation was found
on primary hyperalgesia (heat stimuli). This is consistent with
a study that used repetitive heat stimuli in healthy individuals
and found no effect of motor cortex tDCS stimulation on
heat hyperalgesia (86). Meeker et al. (85) interpreted their
findings as evidence that, due to its effects on secondary
hyperalgesia, M1 likely influences supraspinal circuits that are
altered due to central sensitization. The capsaicin injection
was indeed shown to decrease regional cerebral blood flow
(rCBF) in right the mPFC and increase rCBF in the caudal part
of the right anterior cingulate cortex (ACC) after application
of 1Hz rTMS over right M1, as revealed by single-photon
emission computed tomography (SPECT) (87). Moreover, the
authors showed that pain decreased significantly after active
rTMS compared to sham, and pain reduction significantly
correlated with previously reported rCBF changes in mPFC
and right ACC. This suggests that M1 is strongly related to
mPFC and ACC regions during pain perception (87). In line
with previous findings, Hughes et al. showed that compared
to sham, active tDCS over M1 significantly reduced dynamical
mechanical allodynia and mechanical pain sensitivity initiated
by capsaicin-induced pain applied before tDCS in 12 healthy
subjects. The authors concluded that M1 exhibits top-down
modulation of inhibitory descending pathways to reduce the
increased excitability in the dorsal horn, which has previously
been associated with the development of allodynia (78).
In contrast to previous findings, (77) reported no significant
effect of 10Hz rTMS over the right M1 on motor excitability
nor on the conditioned pain modulation (CPM), a reliable
indicator of endogenous descending inhibitory pain control (88).
Compared to a sham condition, active rTMS delivered over 5
successive days reduced the intensity of the pain induced by
injection of neuronal growth factor (NGF) in the right forearm
of 30 healthy participants. NGF induced pain spanning weeks,
therefore more closely mimicking prolonged pain than capsaicin.
Subjects in both groups developed multifocal, widespread pain,
resembling the pattern seen in the chronic musculoskeletal
pain conditions.
rTMS also reduced muscle soreness, narrowed the painful
area, and increased pressure pain thresholds, and by day
14, the last experimental session, almost completely resolved
muscle soreness and pain. Interestingly, rTMS did not exhibit
significant effects on corticomotor excitability (activated cortical
map volumes were increased over time in a similar fashion
compared with the sham condition). Since the CPM task and
motor excitability remained unaltered, the authors concluded
that the observed effects are neither likely to be the result of
M1 stimulation affecting descending pain inhibition networks,
nor that they might emerge from local changes in M1. They
rather discussed that the beneficial effects might have arose from
changed activity of areas connected to M1 that are involved
in pain processing or in affective processing of pain. Since
these results were not confirmed by imaging, the mechanisms
remained unclear. Nevertheless, it is plausible thatM1 can indeed
affect the activity of ACC, thalamus, insula, or DLPFC, as shown
by imaging studies and by studies using electric field modeling to
determine the current spread after M1 stimulation (89, 90).
Schabrun et al. (91) examined pain processing in an already
sensitized system that resembles chronic conditions. They
trackedM1 transient adaptation in response to saline injection in
addition to NGF injection. The study involved 12 healthy subjects
who were injected with NGF on day 0 and day 2, followed by
an assessment of corticomotor excitability. Hypertonic saline was
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also injected on day 4 to enhance pain in an already sensitized
system and measures of motor function and organization were
assessed during induced pain lasting about 10min, and again
after the pain had resolved. Interestingly, TMS measurement
protocol showed that motor cortex reorganization assessed by
motor maps and number of discrete peaks in M1 activity
occurred as early as on day 4 in response to the onset of
pain and muscle soreness. Corticomotor excitability, assessed
by MEP amplitude, was unchanged directly after the NGF
injection, but increased on day 2 following repeated NGF
injection in an already sensitized system (91). In contrast to
what is known in chronic pain conditions, where the extent of
M1 reorganization was associated with pain severity (75), this
study showed that M1 reorganization was not associated with
the development of pain severity and disability. This suggests
that changes in muscles, rather than pain, are predominately
driving early plasticity (91). Additionally, the authors argue that
M1 reorganization is probably driven by a release of intracortical
networks, as the observed increased intracortical facilitation
enables redistribution of muscle activity from the affected site
to non-affected surrounding areas. Disturbed balance between
inhibitory and facilitatory motor circuits has been observed in
various chronic pain conditions (92), but the results were not
always straightforward.
Given that rapidly occurring neuroplastic changes often
relate to pain duration in chronic pain conditions, it has
been suggested that these changes could be preceding the
chronic stage and therefore represent a risk factor for
chronicity (75, 93). Moreover, individual differences in motor
plasticity could underlie vulnerability to pain development,
with some individuals adopting maladaptive changes due to
abnormalities in pre-existing brain circuits characteristics. For
example, Seminowicz et al. (94) showed that differences in
motor cortex changes in response to NGF injection were
not apparent when analyzed on the group level but emerged
when individuals were divided according to their excitability
responses. In individuals who showed corticomotor facilitation,
motor maps were increased, whereas participants who showed
depressed responses of corticomotor excitability, had reduced
map volumes, and displayed higher pain severity and worse
cognitive performance (94).
DLPFC
Among the studies that have addressed the DLPFC, Fierro
et al. (95) showed how stimulation applied over the DLPFC
affects motor cortex excitability during 1 h of capsaicin-induced
heat pain. The authors first assessed how induced pain affects
corticospinal excitability and short intercortical inhibition (SICI).
As pain developed, reduced corticospinal excitability assessed
by MEP amplitudes was reported together with intracortical
disinhibition on the contralateral motor cortex, evidenced by
SICI using paired-pulse TMS over M1. Interestingly, 5Hz rTMS
over the left DLPFC delivered 10min after capsaicin application
reversed effects observed within the motor cortex, at the same
time lowering pain ratings. The control condition designed
to explore the effects of DLPFC stimulation on motor cortex
excitability in absence of pain showed no effect upon motor
cortex excitability. This suggests that pain might mediate the
relationship between activation of the DLPFC and motor cortex
and that DLPFC influences on pain might induce changes
in the motor cortex. Moreover, such findings also show that
DLPFC stimulation might be able to reverse excitability changes
induced by pain (95). Importantly, motor excitability changes
were associated with concurrent high pain ratings, but as motor
cortex inhibition started to diminish, pain ratings were still high.
These findings suggest that perceived pain intensity was at least
partially independent of the observed changes in excitability of
the motor cortex. This is in accordance with research that used
infusion of hypertonic saline in healthy adults, which supressed
motor evoked potentials immediately as pain reached the pain
threshold, supressed up to 25min after the pain declined. This
could imply that recovery from acute pain itself does not prompt
the brain to change accordingly, since the brain is not only
shaped by the presence or absence of acute, but also by previous
pain-related learning processes (96). This is in line with imaging
evidence of shifted pain processing from nociceptive circuits
to circuits involved in emotion and learning (5). It is thus
conceivable that changed motor function is driving changes in
motor organization, but motor reorganization itself is not a (sole)
generator of chronic pain.
Studies that applied brain stimulation shortly after induced
pain onset showed how a specific region can foster recovery
from pain, but since stimulation was usually initiated when pain
already developed, these studies cannot tell if such a targeted
stimulation would also prevent the development of pain. To
investigate whether stimulation applied before pain onset can
induce early recovery, Seminowicz et al. (97) applied rTMS over
left DLPFC before injecting NGF to the right forearm of 30
healthy subjects. The study protocol involved rTMS stimulation
on 5 consecutive days beginning before first NGF injection
that was applied in the initial experimental session and 2 days
afterwards. Compared with sham TMS, active TMS significantly
reduced pain severity, muscle soreness and the size of the
painful body area compared to sham over time, while depression,
anxiety, Positive and Negative Affect Schedule scores, and pain
catastrophizing scores remained unchanged. There was a trend
toward better performance on an attention task post-stimulation.
The authors concluded that themechanism of action was possibly
either through descending modulatory endogenous circuits or by
affecting cognitive aspects of pain (97). Effects of TMSwere tested
on each of the 5 days of intervention, and up to 14 days and were
stronger on the intervention day and were detectable up to 3 days
after the intervention, which might be indicative of immediate
effects rather than initiation of long-term plasticity-like effects.
NIBS studies underline the importance of the DLPFC in
pain chronicity, since it seems that DLPFC affects not only the
affective but also sensory component of the pain, independently
of motor cortex activation. This is in accordance with a study
in fibromyalgia patients where tDCS over DLPFC modulated
heat pain thresholds (98). In further support of this finding, Lin
et al. showed that pain reduction after DLPFC stimulation was
not related to M1 activity, but rather through direct thalamic
inhibition (99). A naloxone injection interfered with the analgesic
effects of M1 stimulation, while it had no effect on DLPFC
Frontiers in Neurology | www.frontiersin.org 6 August 2021 | Volume 12 | Article 732034
Kandić et al. Brain Stimulation in Pian Chronicity
stimulation, suggesting different mechanisms behind the effects
on pain of these two cortical regions (100). In addition, anodal
M1 tDCS and anodal DLPFC showed differential effects on other
cortical and subcortical areas, as revealed by resting state fMRI
pre and post tDCS stimulation (101).
Notably, structural and functional differences that may
be “prewired” could make individuals more prone to the
development of chronic pain. Lin et al. (99) found that immediate
analgesic effects of anodal tDCS over left DLPFC are dependent
on structural connectivity between left DLPFC and thalamus.
Sham compared to tDCS over DLPFC stimulation revealed
increased blood perfusion in posterior insula and thalamus on
the left side and lower perfusion in M1, implying that these
regions are involved in the processing of ongoing tonic pain,
while anodal tDCS normalized this activity. Specifically, subjects
who showed the strongest structural connectivity between left
DPFC and thalamus, displayed the highest functional coupling
between these two regions during anodal compared to sham
tDCS (99). These findings are in line with previous research
showing that resting state functional connectivity (102, 103),
and individual morphology (104) predict pain sensitivity in
healthy controls. Considering that pain sensitivity is a known
risk factor for chronicity (105), these findings confirm the idea
that structural and functional networks involving DLFPC relate
to pain chronicity.
Brain Targets in Chronic Musculoskeletal Pain
Patients
Motor Cortex
The processing of acute pain can be profoundly altered in chronic
pain conditions, such that distinct patterns of alterations emerge
across several brain regions including somatosensory cortex,
thalamus, insula, motor and cingulate cortices (20, 106–108).
The first study that explored how immediate effects of tDCS
to M1 influence acute pain in chronic pain patients compared
pain ratings to repetitive heat and electric stimuli in chronic low
back patients before and after tDCS, with no significant outcome
(109). In addition, although clinical pain was not the focus of
this study, no effect on ongoing back pain emerged during or
after tDCS compared to baseline or sham (109). Nevertheless,
with improved tDCS parameters such as increased intensity and
smaller, more focal electrodes, anodal tDCS over M1 was shown
to decrease experimental pain scores in chronic low back patients
(110). The peak value of current density was modeled to show
that most of the current was delivered to M1, although one
could not exclude that other regions such as DLPFC or primary
somatosensory cortex (S1) may be affected. Interestingly, low
back muscle activity did not show any differential response to
stimulation (110). This is in line with the previous findings of
prolonged pain in healthy subjects, where motor map volume
remained unchanged after tDCS to M1, whereas pain decreased
(111). These findings suggest that pain changes are not confined
to motor cortex itself, but rather that M1 stimulation conveys its
effect through other interconnected regions, or it acts in synergy
with other regions.
To date, only one study employed non-invasive stimulation
methods to study changes in the acute stage of clinical
musculoskeletal pain. Chang et al. (112) recruited individuals
experiencing acute low back pain lasting <4 weeks to elucidate
which changes previously found in chronic stage of clinical back
pain are present already early in acute clinical pain development.
Employing electroencephalography (EEG), sensory evoked
potentials (SEP) to non-painful electrical stimulation at the
site of pain in area of the paraspinal muscles were recorded.
Compared to healthy controls, corticospinal excitability assessed
by TMS in M1 was lower in the 36 assessed patients. In
addition, patients with low back pain had lower amplitudes of
sensory evoked potentials related to secondary somatosensory
cortex (S2) and ACC regions. Notably, the number of discrete
motor map peaks did not show significant differences between
subjects with and without pain, suggesting that the early phase
of clinical pain development is not characterized by considerable
motor cortex reorganization (112). However, this study was
conducted in a cross-sectional manner. Further studies with
follow-up measurements would be needed to examine whether
the observed changes remained present up to the chronic stage.
Occipital Field
Occipital nerve field stimulation with subcutaneously implanted
electrodes was shown to have positive effects in treating
fibromyalgia (113). De Ridder and Vanneste (114) used source-
localized resting-state EEG and tDCS over the occipital nerve
field (OCF) to investigate mechanisms behind fibromyalgia
pain. Using effective connectivity analyses, the authors showed
that the connectivity changes between pgACC to the dorsal
anterior cingulate cortex (dACC) were causally related to
chronic pain. Specifically, active OCF tDCS compared to
sham normalized disturbed effective connectivity from the
pregenual anterior cingulate cortex to the dorsal anterior
cingulate cortex, with a reduction of clinical pain. Considering
the role of dACC in salience encoding and the role of
pgACC in inhibitory pain control, the authors concluded that
OCF tDCS exerted its modulatory effect via activation of
the descending pain inhibitory pathway and de-activation of
the salience network. Using directional functional connectivity
measures to determine information transmission from one
region to another it was revealed that pain increased with
more information sent from dACC to pgACC, which led the
authors to conclude that fibromyalgia is primarily driven by
increased pain sensitization. Altered activity of pgACC, a part
of the descending inhibitory system, is in accordance with
imaging studies showing that smaller rostral ACC volume and
cortical thickness in fibromyalgia patients were correlated with
pain duration (106). The ACC is an important relay in the
medial pain pathway and since it integrates sensory, attentional,
and motivational components of pain, it could have a pivotal
role in the development of chronic pain (115). Disrupted
functional and structural connectivity between cingular areas and
striatal regions have also been shown to be a predictor of the
development of chronic pain (18).
Primary Somatosensory Cortex
rTMS and tDCS are themost prominent non-invasive techniques
used in chronic pain studies. Oscillatory protocols such as tACS
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are largely unexplored and underrepresented in pain research
(116). To date, only one study has examined tACS-related
effects in chronic pain patients. Ahn et al. (117) administered
10Hz tACS bilaterally over the S1 and showed reduction in
ongoing back pain and disability ratings in chronic low back pain
patients. In addition, this reduction correlated with increased
alpha oscillations in the regions under the electrodes, but also
within frontal areas, as documented by electrophysiological
recordings (117). These findings suggest a causal relationship
between somatosensory alpha oscillations and ongoing chronic
pain and is in line with previous research that found associations
between manipulations of neural activity at the alpha frequency
in somatosensory cortices and the processing of phasic heat pain
(118). However, the latter study showed that reduction in pain
is dictated by the context of the painful stimuli, namely that
tACS has an influence only when the intensity of the painful
stimuli was uncertain. Moreover, electrophysiological studies
indicated that the intensity of ongoing pain in chronic back pain
patients is encoded by prefrontal gamma activity (119). This
points to a prefrontal involvement in the early and subsequent
evolvement of pain. These findings are consistent to the ones
of Ahn et al. (117) since they found significant associations of
pain severity not only with the somatosensory cortex, but also
alpha oscillations in frontal regions. However, the question of
the specificity of a certain region and its endogenous frequencies
that give rise to the pain experience as it temporally unfolds,
prompts further research that would combine stimulation and
electrophysiological methods and utilize different types of pain.
In accordance with what we know so far from imaging studies (5,
120, 121), it is conceivable that acute phasic pain is predominately
processed by somatosensory cortices and subserved by its
intrinsic frequencies. But when pain develops, a shift toward
prefrontal areas was shown, and hence the longer lasting and
chronic pain may primarily be governed by rhythmic activity in
prefrontal regions (116). This does not exclude that activity in
somatosensory regions might also change in response to chronic
pain, as well as a possible interplay between alpha and gamma
frequencies, known to engage in cross-frequency coupling and
modulating each other (122).
FUTURE DIRECTIONS
Medial Prefrontal Cortex as an Additional
NIBS Target
With respect to the non-invasive stimulation targets, only very
recently additional targets such as the medial prefrontal cortex
were investigated in chronic pain patients. In a study that
attempted to modulate clinical pain manifestations via affective
and attentional manipulations, chronic low back patients
underwent active and sham HD-tDCS over the medial prefrontal
cortex (123). Conditioned pain modulation was not altered by
attentional and affective manipulations, and in addition HD-
tDCS compared with sham did not show effects on themagnitude
of the effects of these manipulations. However, as the authors
acknowledged, the small sample size and the inclusion of only
mild clinical pain might be the main reasons for the absence of
an effect. Further studies with larger sample size and including
severe clinical pain are needed to further our understanding of
the role the mPFC in chronic musculoskeletal pain. Noteworthy,
connectivity patterns of the mPFC were shown to be altered
in chronic back pain (102, 124) and have been suggested as a
predictor for pain chronicity (18, 30). A two-fold role of mPFC as
a site exhibiting opposing effects on pain has also been suggested:
it is a relay between higher and downstream areas in modulating
pain perception, and its dysfunction can lead to chronicity
via projections to striatal reward pathway that could lead to
overstimulation of the thalamus and possibly of the insula (125).
Due to the substantial body of mPFC neurotransmitters that tune
the prefrontal processing of affective components of pain, mPFC
has also been proposed as a central hub subserving cognitive and
affective comorbidities seen in chronic pain states (126).
NIBS Mechanistic Interference Framework
Studies that would be suited to mechanistically investigate the
role of specific brain circuits in the development of chronic
pain would have to consider several factors. Firstly, we could
target neural activity previously found to be associated with
and/or predictive for the development of musculoskeletal pain
to investigate immediate effects of such a manipulation on pain
regulation and demonstrate causal relation to chronicity. Studies
thus far used either excitatory or inhibitory stimulation protocols
depending on the method in question to potentiate analgesic
effects, but rarely focused on up and downregulation with the
aim to investigate a causal involvement of targeted area in pain
processing. For instance, since it has been shown that activity
in prefrontal brain regions in relation to spontaneous pain is
increased in CBP patients (16), neuromodulation that inhibits
prefrontal activity should decrease spontaneous clinical pain. In
the same vein, if stimulated in an excitatory manner, prefrontal
activity should amplify pre-existing overactivation and result in
upregulation of pain intensity.
However, there are inherent challenges related to NIBS studies
in chronic pain aiming to arrive to mechanistic explanations. A
common non-invasive stimulation approach to investigate the
causal role of a brain region in a specific behavioral or cognitive
domain follows the “virtual lesion” principle. Hereby brief
disruption of normal brain activity leads to immediate effects
on the behavioral and/or cognitive level reflected by a changed
response to the experimental task (51). Given that chronic
pain is a subjective experience and thus is not experimentally
induced, the task in this case is highly reliant on the subjects’
perception and ability to transfer that perception into self-
reported pain ratings. On the same grounds, chronic ongoing
pain cannot be precisely time-locked to the stimulation as it can
be for other experimental stimuli, such as, for example, visual
stimuli delivered with millisecond precision concurrent with
a stimulation pulse (127). In addition, stimulation procedures,
particularly TMS, can themselves be painful depending on
the site of the stimulation (128), hence they can interfere
with the perception of ongoing clinical pain. Due to all these
reasons, effects are investigated post-stimulation rather than in
an online fashion, which, however, imposes time delay and make
effects more indirect (129). If explored online, i.e., during the
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stimulation, caution should be takenwhen interpreting the effects
on chronic ongoing pain.
Next, careful consideration of the control conditions is a
prerequisite toward more conclusive mechanistic interference.
Sham procedures ensure the control of non-specific effects of
TMS such as placebo effect, auditory noise, or sensory percepts
of pulse discharge. To evaluate specificity of the brain region,
TMS can be applied over another area presumably not involved
in pain processing (129). To confirm behavioral specificity,
effects of the targeted area should be confined to the task in
question (130), in this case to the (pre)chronic ongoing pain. This
could be examined by introducing a control task that requires
neural processes that are not involved in pain perception,
such as, for example, visuo-motor coordination (16). The
power of mechanistic evidence increases with increasing control
conditions (130), but also decreases statistical power. There is
therefore a compromise to be found between the choice of control
conditions and the conclusive mechanistic interference.
Importantly, our recent tACS studies emphasize the need for
an active control condition to explicitly test frequency specificity,
which is usually ignored in most NIBS studies to date (131, 132).
NIBS studies should follow the general recommendations in
terms of good scientific practice for planning a tACS experiment,
which include the recommendation to choose an appropriate
control frequency to demonstrate frequency specificity (54, 133).
Following this rationale, the optimal control condition would be
a frequency at which no modulatory effect would be expected.
Therefore, it is important to avoid a synchronization between the
frequency of interest and the control frequency.
Precise targeting is necessary to restrict stimulation effects
to the desired region. Due to intrasubject variability, MRI-
based TMS neuronavigation should be preferred instead of the
traditional 10–20 EEG system positioning that is less accurate and
has been found to induce different electrical field distributions
compared to imaging-based localization (134, 135).
Next, to track which changes are pre-existing in the chronic
stage and at the same time putative causes of chronicity, NIBS
interventions might be introduced in the acute and then to
and in the subacute stage. In this manner, any brain activity-
pain relation found before the chronic stage would be marked
as a potential risk factor for pain chronicity. In contrast to
brain imaging studies which enable mainly correlational evidence
between brain activity and pain, NIBS would provide controlled
manipulation cause-effect relationships.
Combining NIBS With Imaging and
Electrophysiological Methods
The mapping of NIBS-related effects could be performed by
combining NIBS and imaging or NIBS and electrophysiological
methods. Non-invasive stimulation is primarily confined to the
superficial cortical layers (38), but via interconnected areas it can
have an effect on subcortical regions. Therefore, the stimulation
effect of the target could be fully prescribed to the activation of
deeper layers (40). Due to these reasons, more conceivable and
more precise mechanistic explanations would require imaging
the effects of the induced stimulation immediately after the
intervention to obtain a clearer picture of the affected circuits.
Previous studies showed that tACS can induce BOLD changes
even in the absence of behavioral modulations (136–138).
Different stimulation frequencies can lead to both an increase
and a decrease of brain activity. Moreover, the frequency range
in which the change in brain activity occurs can coincide with
the stimulation frequency, or lie in a different frequency range
(131, 139).
Since it is conceivable that complex perception such as the
pain experience depends on several key factors, the neuronal
network on a whole, rather than an isolated brain region, is
highly likely to be affected as pain progresses to the chronic state.
One specific characteristic of the neural network is its oscillatory
activity (140), thus its exploration could aid our understanding
of the role of brain networks in the transition to chronic pain.
From the pool of non-invasive stimulation methods, rTMS and
tACS emerge as approaches able to influence intrinsic rhythmic
activity via the proposed mechanism of entrainment (68). This
concept refers to synchronization of the rhythmic activity of a
physical system to an external periodic oscillator (141), and in
case of neural endogenous oscillations reflects their coupling to
the stimulator (67). rTMS and tACS can act in a frequency-
specific manner (68), and thus a causal role of brain oscillations
and regions that recruit them could be investigated in (pre)-
chronic pain patients. Electrophysiological research showed an
association between prefrontal gamma activity and ongoing back
pain intensity, indicating therefore that the prefrontal areas
are vital parts of long-lasting pain development, showing that
medial prefrontal cortex encodes tonic pain at the gamma
frequency in healthy controls (142), and changes in prefrontal
gamma activity are associated with changes in ongoing back
pain intensity (119). It remains however unknown if additional
oscillation frequencies could be involved in pain chronicity, and
this deserves further investigation.
To date, only one study in chronic musculoskeletal pain
patients at our knowledge, combined tACS and EEG to
successfully demonstrate an impact on chronic low back pain via
an influence on somatosensory alpha frequencies (117). Network
pathology in chronic musculoskeletal pain should be further
investigated because for instance, cross-frequency coupling could
subserve interactions between large-scale neural networks and
local dynamics (122). If applied in a longitudinal framework, such
research could, in addition, reveal whether the communication
within constituents of brain networks is affected in the states
preceding chronic pain development, or at which time point such
alterations possibly emerge.
CONCLUDING REMARKS AND
IMPLICATIONS FOR CLINICAL PRACTICE
Overall, there is a great need to employ the NIBS interference
framework to elucidate changes in brain circuits as potential
causal factors of the development of chronic musculoskeletal
pain. This research should be built upon previously demonstrated
significant predictors of chronicity in imaging studies that
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provide potential targets of non-invasive stimulation. Non-
invasive stimulation applied in models of prolonged pain or in
chronic musculoskeletal pain patients thus far seems to confirm
the importance of prefrontal regions in the transition to chronic
pain. Importantly, NIBS showed that interventions applied
preceding or in an early time windows of long-lasting pain can
revert maladaptive responses. Moreover, NIBS findings point
to the relevance of the connectivity patterns and deeper areas,
justifying their targeting by methods such as neurofeedback
(143). Additionally, it highlights fast plastic changes in the
motor cortex in response to pain onset, alongside interindividual
differences, which calls for more investigation. Here, studies in
other pain conditions may also provide important information.
The results for chronic musculoskeletal pain are mirrored in
studies on neuropathic pain suggesting that there might be
considerable overlap in the brain processes between the two types
of pain. This has been demonstrated, for example, very recently
in a study by Attal et al. (144), where it was shown that M1-
rTMS, but not DLPFC-rTMS, induces significant effects on pain
intensity changes compared to sham-rTMS.
Furthermore, an intact descending inhibitory pathway seems
necessary to counteract early maladaptive changes associated
with central sensitization, although this could be related to
the predominance of central sensitization in the mechanism
behind symptoms, since not all chronic pain patients exhibit
CS symptoms (145). It has been demonstrated that chronic
conditions with absence of any tissue injury exhibit less
efficient descending pain modulatory system as assessed by
the CPM paradigm (146). At the same time, symptoms of
central sensitization are not necessarily alone good predictors
of chronicity, but rather work jointly with other factors
such as psychological determinants, as shown in an acute
stage of low back pain using the CPM paradigm and pain
thresholds (147). Nevertheless, pain management directed at
restoring functionality of descending inhibitory pathways in
an early manifestation of the central sensitization phenomena
could have important implications for chronic pain patients
that exhibit those symptoms. Previous studies indicate that
state-triggered and closed loop stimulation boosts effects
of non-invasive transcranial brain stimulation [for review,
see (148)].
Employment of novel variants of non-invasive stimulation,
such as theta burst stimulation that has a potential for more
reliable excitatory and inhibitory effects on brain regions (149),
should be encouraged in an interference driven approach. This
method successfully ameliorated pain in several other chronic
pain conditions such as chronic orofacial pain, complex regional
pain syndrome, and central neuropathic pain (150–152) and thus
incites therapeutic applications. Another recent NIBS approach,
a form of tACS called transcranial random noise stimulation
(tRNS), has proven efficient to consistently induce increased
cortical excitability with effects lasting up to 1 h after the
stimulation (153). tRNS uses the alternating electric current
following a random white noise spectrum (54). In addition,
stimulation in high frequency range (80–250Hz) was shown
to be a potent stimulation protocol to increase human cortical
excitability during and after the end of stimulation (154), opening
a possibility to explore such a protocol in pathological conditions.
A multi-coil magnetic stimulation design shown to modulate
anterior cingulate cortex in fibromyalgia patients could be one
possibility to effectively target deeper areas (155).
Last, spinal cord stimulation (SCS), as another well-
established therapeutic option for the treatment of chronic
pain, has also been examined for patients with chronic back
pain, specifically those with failed back syndrome (156). A
functional imaging study in patients with chronic pain showed
that SCS reduced pain sensation along with abnormal functional
connectivity between somatosensory and limbic circuits and
increased the connectivity between somatosensory areas and the
default mode network (157). These data also point to a close
interaction of sensory and emotional processing networks in
chronic pain that could be targeted in treatment.
A mechanistic understanding of the transition from acute to
chronic musculoskeletal pain is needed to permit targeted early
intervention (158). However, our knowledge of chronic pain
mechanisms is still limited and the evidence for mechanistically
guided treatments is sparse.
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